Mesorectal excision with lateral lymph node dissection versus without lateral lymph node dissection for clinical stage II, III lower rectal cancer(JCOG0212)
Phase 3
- Conditions
- Stage II, III lower rectal cancer
- Registration Number
- JPRN-C000000034
- Lead Sponsor
- Japan Clinical Oncology Group(JCOG)
- Brief Summary
See the datails via "URL releasing results" above. Also the details can be seen in the JCOG website: http://www.jcog.jp/en/trials/index.html
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 700
Inclusion Criteria
Not provided
Exclusion Criteria
1) Multiple cancer patients 2) Pregnant patients 3) Psychological disorder 4) Steroid administration 5) Cardiac infarction within six months 6) Severe pulmonary emphysema and pulmonary fibrosis 7) Doctor' s decision for exclusion
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Relapse-free survival
- Secondary Outcome Measures
Name Time Method Overall survival, Local-recurrence-free survival, Incidence of adverse events, Incidence of major adverse events, Operative time, Blood loss, Incidence of sexual and urinary dysfunction